All Professionals
Overview
Meiyi Li is an associate in the Corporate Department of Paul Hastings and is based in the firm’s Hong Kong office. Meiyi’s practice focuses on securities offerings, post-IPO compliance and other general corporate matters. Meiyi is fluent in Mandarin, Cantonese and English.
Prior to joining Paul Hastings, Meiyi worked in the corporate department of two leading international law firms with headquarters based in the U.S.
Education
- Columbia Law School, LL.M. 2023
- Nanjing University, LL.B., BSc in Finance, 2018
Representations
- MeiG Smart Technology Co., Ltd., a leading provider of wireless communication modules and solutions listed on the Shenzhen Stock Exchange, on its US$149 million global offering and listing its H shares on the Main Board of the Hong Kong Stock Exchange.
- Delton Technology Guangzhou Inc, a leading manufacturing company that develops, manufactures and sells customized printed circuit boards (PCBs) for high performance servers and other computing applications listed on the Shenzhen Stock Exchange, on its US$423 million global offering and listing its H shares on the Main Board of the Hong Kong Stock Exchange.
- CICC, Goldman Sachs and Morgan Stanley as the joint sponsors, overall coordinators, joint global coordinators, joint bookrunners, and joint lead managers and other underwriters on the US$1.3 billion global offering and listing of H-shares of Foshan Haitian Flavouring and Food Company Ltd., one of the leading condiment companies based in China, on the Main Board of the Hong Kong Stock Exchange. This is one of the largest A+H IPOs in 2025 and the first A+H dual-listed company in the condiments industry. This transaction was awarded “Deal of the Year 2025” by China Business Law Journal.
- CICC and UBS Securities as the joint sponsors, overall coordinators, joint global coordinators, joint bookrunners and joint lead managers, and other underwriters, on the US$437 million global offering and listing of H-shares of Ningbo Joyson Electronics Corp, a China-based intelligent automotive technology solution provider listed on Shanghai Stock Exchange, on the Main Board of the Hong Kong Stock Exchange.
- CICC and Haitong International as the joint sponsors, sponsor-overall coordinators, overall coordinators, joint global coordinators, joint bookrunners and joint lead managers and other underwriters on the US$41 million global offering and listing of H-shares of Unisound AI Technology Co., Ltd., an AI solution provider focusing on the sale of conversational AI products and solutions for daily life and healthcare in China, on the Main Board of the Hong Kong Stock Exchange.
- Goldman Sachs and CICC as the joint sponsors, joint global coordinators and underwriters, UBS as the financial advisor and joint global coordinator and underwriter, together with other underwriters, on the US$1.5 billion global offering and dual primary listing of Li Auto Inc. (HKSE:2015) on the Main Board of the Hong Kong Stock Exchange.*
- Morgan Stanley and Jefferies as the joint sponsors, joint global coordinators and underwriters, Haitong International Securities as the joint global coordinator and underwriter, together with other underwriters, on the US$88 million global offering and listing of CANbridge Pharmaceuticals Inc. (HKSE:1228), a leading biopharmaceutical company with a focus on rare diseases and gene therapy, on the Main Board of the Hong Kong Stock Exchange.*
- Alphamab Oncology (HKSE:9966), a leading clinical-stage biopharmaceutical company in China, on its US$234 million global offering and listing on the Main Board of the Hong Kong Stock Exchange.*
- CanSino Biologics Inc. (HKSE:6185), a biotech leader specializing in vaccine products for human use in China, on its US$160.5 million global offering and listing on the Main Board of the Hong Kong Stock Exchange.*
- CICC, J.P. Morgan and Nomura as the joint sponsors, joint global coordinators and underwriters, together with other underwriters, on the US$195 million global offering and listing of Viva Biotech Holdings (HKSE:1873), a leading structure-based, integrated drug discovery platform, on the Main Board of the Hong Kong Stock Exchange.*
- Haidilao International Holding Ltd. (HKSE:6862), a globally leading and fast-growing Chinese cuisine restaurant brand, on its US$964 million global offering and listing on the Main Board of the Hong Kong Stock Exchange.*
- CMS and CSIC as the joint sponsors, joint global coordinators and underwriters, together with other underwriters, on the US$126 million global offering and listing of Strawbear Entertainment Group (HKSE:2125), a major drama series producer and distributor in the PRC covering the investment, development, production and distribution of TV series and web series, on the Main Board of the Hong Kong Stock Exchange.*
- Yum China Holdings, Inc. (HKSE:9987; NYSE: YUMC), the largest restaurant company in China, on its US$2.2 billion global offering and secondary listing on the Main Board of the Hong Kong Stock Exchange. Its flagship brands include KFC and Pizza Hut, as well as emerging brands such as Little Sheep, Huang Ji Huang, COFFii & JOY, East Dawning, Taco Bell and Lavazza.*
- Rizhao Port Jurong Co., Ltd. (HKSE:6117), the largest port for grain and woodchip imports in China, on its US$69.7 million global offering and listing on the Main Board of the Hong Kong Stock Exchange.*
- Huatai and Credit Suisse as the joint sponsors, joint global coordinators and underwriters, on the global offering and listing of China Youran Dairy Group Limited (HKSE:9858), a leader in China’s upstream dairy market with an all-round business extending from breading, feed to raw milk production.*
* Matters may have been completed before joining Paul Hastings.